balance equationreview2019-12-31
Difference 40772369 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$1.92B
Fiscal year ended 2025-12-31Net income
-$85.55M
Fiscal year ended 2025-12-31Total assets
$541.01M
Fiscal year ended 2025-12-31CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported revenue of $1.92B and net income of -$85.55M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from CLOVER HEALTH INVESTMENTS, CORP. /DE’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $672.89M | $462.27M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | $257.33M | $70.24M | -$79.18M | Unavailable | Unavailable |
| Operating income | -$85.53M | -$45.75M | -$205.33M | -$286.66M | -$636.99M | -$92.71M | -$183.20M |
| Net income | -$85.55M | -$43.01M | -$213.36M | -$339.57M | -$587.76M | -$136.39M | -$363.74M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 511.97M | shares 490.02M | shares 482.18M | shares 476.24M | shares 412.92M | shares 88.69M | shares 87.83M |
| Pretax income | -$85.55M | -$43.01M | -$213.36M | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Diluted EPS | Unavailable | Unavailable | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $214.27M | $176.48M | $183.09M | $203.68M | $185.29M | $120.83M | $95.70M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $78.30M | $194.54M | $122.86M | $103.79M | $299.97M | $92.35M | $67.60M |
| Total assets | $541.01M | $580.74M | $570.67M | $808.62M | $950.80M | $267.25M | $100.35K |
| Current assets | $307.86M | $343.12M | $427.97M | $625.00M | $752.55M | $189.78M | $0 |
| Total liabilities | $232.31M | $239.60M | $284.28M | $451.73M | $410.76M | $432.70M | $117.98K |
| Current liabilities | $208.82M | $213.52M | $261.12M | $431.51M | $371.90M | $164.23M | $117.98K |
| Total equity incl. NCI | $308.70M | $341.14M | $286.39M | $356.89M | $540.04M | -$613.19M | -$488.54M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | $0 | $0 | $0 | $447.75M | $447.75M |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | Unavailable | Unavailable | $0 | $11.75M | $1.24M | $1.24M | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | $0 | $19.94M | $106.41M | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$66.93M | $34.84M | -$144.66M | -$203.93M | -$282.33M | -$118.50M | -$159.88M |
| Capital expenditures | $2.04M | $1.56M | $584.00K | $4.47M | $723.00K | $693.00K | $23.00K |
| Investing cash flow | $4.08M | $565.00K | $140.01M | $95.13M | -$435.45M | $137.40M | -$181.91M |
| Financing cash flow | -$53.38M | -$17.36M | -$5.07M | -$4.96M | $925.39M | $5.84M | $333.98M |
| Net change in cash | -$116.24M | $18.05M | -$9.72M | -$113.76M | $207.62M | $24.75M | -$7.80M |
| Stock-based compensation | $103.66M | $114.33M | $140.93M | $164.30M | $163.72M | $7.08M | $3.30M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $18.30M | $1.77M | $0 | $0 | $147.00K | $0 | $0 |
| Depreciation & amortization | $1.69M | $1.33M | $2.51M | $1.19M | $1.25M | $555.00K | $551.00K |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Free cash flow | -$68.98M | $33.29M | -$145.25M | -$208.39M | -$283.05M | -$119.19M | -$159.90M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | -4.4% | -3.3% | -16.3% | -26.1% | -43.3% | -13.8% | -39.6% |
| FCF margin | -3.6% | 2.4% | -11.5% | -19.0% | -19.2% | -17.7% | -34.6% |
| SBC / revenue | 5.4% | 8.3% | 11.2% | 15.0% | 11.1% | 1.1% | 0.7% |
| Current ratio | 1.47x | 1.61x | 1.64x | 1.45x | Unavailable | 1.16x | 0.00x |
| Revenue YoY growth | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | 45.6% | Unavailable |
| Net margin | -4.4% | -3.1% | -16.9% | -31.0% | -39.9% | -20.3% | -78.7% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.1% | 0.1% | 0.0% | 0.4% | 0.0% | 0.1% | 0.0% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLOV in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.